[1] ARKFELD D G.The potential utility of B cell-directed biologic therapy in autoimmune diseases[J].Rheumatol Int,2008,28(3):205-215.
[2] BELINGHERI M,LAZZARI L,PARAZZI V,et al.Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis[J].Biologicals,2013,41(6):439-445.
[3] 李俊霞,周欣谕,丘美兰,等.脐带间充质干细胞对难治性肾病综合征的疗效观察[J].中华细胞与干细胞杂志(电子版),2016,6(2):92-96.
[4] MA H,WU Y,XU Y,et al.Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis[J].Am J Med Sci,2013,346(6):86-493.
[5] YANG R C,ZHU X L,WANG J,et al.Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models[J].BMC Nephrol,2018,19(1):335.
[6] SHI Y,XIE J,YANG M,et al.Transplantation of umbilical cord mesenchymal stem cells into mice with focal segmental glomerulosclerosis delayed disease manifestation[J].Ann Transl Med,2019,7(16):383.
[7] GULATI A,SINHA A,JORDAN S C,et al.Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome:multicentric report[J].Clin J Am Soc Nephrol,2010,5(12):2207-2212.
[8] MAGNASCO A,RAVANI P,EDEFONTI A,et al.Rituximab in children with resistant idiopathic nephrotic syndrome[J].J Am Soc Nephrol,2012,23(6):1117-1124. |